Covid. Monoclonal antibodies, first Irpinia treated with Moscati

Avellino. At the “San Giuseppe Moscati” hospital in Avellino, the first administration in Irpinia of monoclonal antibodies as a therapy for the treatment of Covid-19 disease. Thanks to a synergy between General Practitioners, Asl Avellino and the Hospital, this morning a 46-year-old was able to benefit from the precious drug. The woman, resident in Avellino, was placed on the special platform by her General Practitioner. Identified by the ASL as having the necessary requisites, it was reported to the Moscati hospital. And this morning she arrived aboard an ambulance from the Usca (Special Continuity Care Units) to the hospital city and was accompanied to a specially set up outpatient clinic on the ground floor of the Covid Hospital. Here the Director of the Internal Medicine Operating Unit, Maria Amitrano, together with other collaborators, first verified the actual possession of the eligibility criteria and then proceeded to infuse the drug, also collected in the morning from the Monaldi Hospital in Naples, after having received the authorization from Aifa, the Italian Medicines Agency.

The infusion operation, constantly monitored, lasted about an hour. The same is true for the patient’s observation period after administration. The 46-year-old was then taken back to her home, where she was also contacted by the Moscati professionals, returning good news about her state of health. “The woman had all the specific characteristics to be subjected to monoclonal therapy – highlights Maria Amitrano -: she presented risk factors for previous pathologies, she was symptomatic with cough, fever and asthenia, but with a level of saturation such as not to require oxygen therapy nor the hospitalization. The infusion went smoothly and the hope now is that the drug will actually prove effective ».

The treatment with monoclonal antibodies is part of the outpatient therapies also activated in Campania to prevent the most serious forms of the disease from developing, and at the same time to lighten the burden of hospitals, especially as regards the employment of therapies intensive. «The contribution that the Moscati Company is offering to the fight against the new Coronavirus – underlines the General Manager, Renato Pizzuti – is becoming increasingly significant, thanks to the great commitment and tireless work of health professionals. The moment is particularly difficult: the number of hospitalizations is considerable, intensive care is full and there are already several operating units converted into Covid areas. Despite this, we are proceeding with the vaccination of fragile patients, we have started the experimentation of the Reithera vaccine and from today we are collaborating with the ASL for the administration of monoclonals. An important effort to lend a hand to the entire community ».